
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
ONWARD MEDICAL BV EO -,12 63E NL0015000HT4 BAW/UFN
© 2024 Xetra Newsboard
Realtime | Geld | Brief | Zeit |
---|---|---|---|
4,050 | 4,070 | 09:33 | |
4,050 | 4,070 | 09:30 |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
30.04. | ONWARD Medical NV: ONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders and Proposed Resolutions | EINDHOVEN, the Netherlands, April 30, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX ONWRY), the medical technology company creating innovative spinal cord stimulation therapies... ► Artikel lesen | |
28.04. | ONWARD Medical NV: ONWARD Medical Announces Release of 2024 Annual Report | EINDHOVEN, the Netherlands, April 28, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement... ► Artikel lesen | |
24.04. | ONWARD Medical NV: ONWARD Medical Establishes US ADR Program and Begins Trading on OTCQX Best Market | Sponsored Level 1 ADR program facilitates trading by US investors following recent FDA clearance and commercial launch
BNY will be ADR depositary bank
Ticker symbol for US investors is ONWRY
EINDHOVEN... ► Artikel lesen | |
23.04. | OTC Markets Group Welcomes ONWARD Medical N.V. to OTCQX | NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced ONWARD Medical... ► Artikel lesen | |
01.04. | ONWARD Medical NV: ONWARD Medical Reports Full Year 2024 Financial and Operating Results and Shares 2025 Year-to-Date Highlights | Received FDA authorization and recorded first commercial sales of ARC-EX System
Secured strategic investment from Ottobock and extended cash runway for two years
Gained exclusive rights to premier... ► Artikel lesen |